Finance

Lists
603351:SHA
Nanjing Well Pharmaceutical Group Co Ltd
CNÂ¥25.27
+0.28%
(+0.070) 1D
Sep 11, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603351...
Open
CNÂ¥25.20
High
CNÂ¥25.41
Low
CNÂ¥24.75
Mkt. cap
3.42B
Avg. vol.
1.41M
Volume
764.60K
Dividend
2.37%
Quarterly dividend
CNÂ¥0.15
Ex-dividend date
Jun 5, 2026
P/E ratio
22.08
52-wk high
CNÂ¥30.80
52-wk low
CNÂ¥21.90
EPS
CNÂ¥1.14
No. of employees
718
Open
CNÂ¥25.20
High
CNÂ¥25.41
Low
CNÂ¥24.75
Mkt. cap
3.42B
Avg. vol.
1.41M
Volume
764.60K
Dividend
2.37%
Quarterly dividend
CNÂ¥0.15
Ex-dividend date
Jun 5, 2026
P/E ratio
22.08
52-wk high
CNÂ¥30.80
52-wk low
CNÂ¥21.90
EPS
CNÂ¥1.14
No. of employees
718
About Nanjing Well Pharmaceutical Group Co Ltd
CEO-
Employees718
FoundedFeb 18, 2000
Headquarters-
SectorCommodity chemical
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
344.52M
316.80M
356.30M
383.29M
Cost of goods sold
240.25M
232.82M
258.38M
279.80M
Cost of revenue
240.25M
232.82M
258.38M
279.80M
Research and development expenses
22.83M
20.55M
19.09M
21.08M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33.00M
25.44M
27.73M
33.67M
Operating expense
54.62M
47.14M
48.21M
55.06M
Total operating expenses
294.87M
279.96M
306.58M
334.86M
Operating income
49.65M
36.83M
49.72M
48.43M
Other non operating income
-366.27K
220.72K
-2.06M
1.94M
EBT including unusual items
47.72M
39.07M
43.92M
46.03M
EBT excluding unusual items
46.87M
33.62M
43.93M
45.70M
Income tax expense
7.29M
1.82M
7.07M
7.36M
Effective tax rate
15.27%
4.65%
16.11%
15.98%
Other operating expenses
-1.05M
1.06M
506.84K
372.91K
Net income
41.30M
36.90M
37.63M
39.15M
Net profit margin
11.99%
11.65%
10.56%
10.21%
Earnings per share
-
-
-
-
Interest and investment income
267.66K
85.57K
113.84K
360.14K
Interest expense
-2.41M
-2.32M
-3.85M
-2.56M
Net interest expenses
-2.14M
-2.23M
-3.73M
-2.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
76.35M
67.52M
80.41M
79.05M
Gain or loss from assets sale
6.48K
-16.25K
-
-
AI content may include mistakes. Learn more
Google apps